The DOI matches its Crossref record; 183 of the 185 references it cites were found in a registry or an index.
The medical complications of obesity
Abstract
The prevalence of overweight and obesity is increasing worldwide. 1 A comparison of data from 1976–80 2 with that from 1999–2000 shows that the prevalence of overweight (defined as body mass index, BMI, of 25–29.9 kg/m 2 ) increased from 46% to 64.5%, and the prevalence of obesity (BMI ⩾ 30 kg/m 2 ) doubled to 30.5%. The epidemic of obesity is not just isolated to the US, but is worldwide, 3,4 including less affluent countries. 4 Obesity and overweight have many causes, including genetic, metabolic, behavioural and environmental. The rapid increase in prevalence suggests that behavioural and environmental influences predominate, rather than biological changes. We summarize data from many studies evaluating the impact of obesity on mortality and morbidity, discuss some controversies and provide practical guidelines for managing obese patients. Direct associations between obesity and several diseases, including diabetes mellitus, hypertension, dyslipidaemia and ischaemic heart disease, are well recognized. Despite this, the relationship between body weight and all-cause mortality is more controversial. A very high degree of obesity (BMI ⩾35 kg/m 2 ) seems to be linked to higher mortality rates, 5 but the relationship between more modest degrees of overweight and mortality is unclear. Initial data from actuarial studies of more than 4 million men and women showed a direct positive association between body weight and overall mortality rates. 6 Subsequent studies confirmed increased mortality risk above a certain threshold, but found a U-shaped association between weight and mortality. 7,8 In the Build study, 9 there was a higher mortality in lean subjects, but there was no adjustment for smoking. The American Cancer Society found a much stronger association between leanness and mortality, specifically cancer mortality, in the group of smokers compared to non-smokers. 10 The Harvard Alumni Study 11 was a prospective cohort study of more than 19 000 middle-aged men. It also noted a U-shaped relation between BMI and mortality after adjustment for age, cigarette smoking and physical activity. However, after excluding those who had ever smoked and those who died within the first 5 years of follow-up, there was no evidence for increased mortality in those with a BMI <22.5 kg/m 2 and the lowest mortality was noted in those who weighed 20% below the average. A direct relationship between BMI and mortality was also described in a cohort of more than 8000 Seventh Day Adventists, with the lowest mortality rate found in men with a BMI <22.3 kg/m 2 . 12 This group is usually lean by choice, and therefore their leanness is less likely to be the result of cigarette smoking or underlying illness. Obesity has also been associated with an increased risk of mortality in women. There have been some reports that did not find a relationship between BMI and mortality in women, 13–15 but due to the small number of endpoints occurring in these cohorts, these studies lacked sufficient power. Several larger studies showed a significant association between body weight 8–10 or BMI and mortality. 16 Notably, the Nurses’ Health Study, showed a U-shaped relationship between BMI and all-cause mortality. 16 Another recent study found a U-shaped association between weight and mortality in a large cohort of Chinese men and women. 17 There are several explanations for the discrepancies observed in the above epidemiological studies. There may be an adverse effect of leanness and leanness can be a surrogate marker of underlying diseases. 18 The possibility that there may be some beneficial effect of mild degree of excess body weight on overall survival, also cannot be entirely ruled out. For example, in the INTERHEART study, high hip circumference had a negative predictive value for myocardial infarction, while high waist circumference was associated with high rates of myocardial infarction, implying that considering only the BMI and ignoring fat distribution may be misleading. 19 Weight or BMI may be relatively low in an elderly person with little lean body mass relative to adipose tissue. The correlations between BMI and more direct measures of adiposity (e.g. underwater weighing) range between 0.6 and 0.8. 20,21 Furthermore, reported correlations between waist–hip ratios and visceral adipose tissue volume (as assessed by CT) are imperfect. 22 Other limitations of several epidemiological studies are: partial adjustment for confounding factors (such as physical fitness, type of diet, family history, weight cycling, use of diet drugs, economic status), inclusion of self-reported data, not taking into account the age of onset of obesity and not estimating the obesity-attributable mortality. It has been estimated that the excess mortality associated with obesity in the Framingham study is due to the effect of weight cycling, and that participants with stable body weights were not at increased risk. 23 A similar finding has been reported in the Nationa
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity is associated with an increased risk for T2D, hypertension, dyslipidaemia, cardiovascular diseases, musculoskeletal disorders (such as osteoarthritis), certain types of cancer, and premature mortality.19,20”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [19]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“3 years, and resulted in a 58% reduction in diabetes incidence.(172) For morbidly obese persons with a high-risk profile or the above-mentioned complications, who fail to lose weight, pharmacological adjunct therapy and bariatric surgery should be considered.”
BackgroundThe Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183 · cited 1×
“Epidemiological evidence from the Wisconsin Sleep Cohort Study showed that sleep apnoea risk increased significantly with obesity.(75) A neck circumference 417 inches, which is correlated with obesity, has also been highly correlated with OSA.”
Background(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205 · cited 1×
“Hypertension, left atrial enlargement and congestive heart failure are all strongly linked to atrial fibrillation (AF).(57,58) Despite the close relationship between obesity and several of the risk factors for AF, a clear relationship between AF and obesity has only recently been established.”
BackgroundPrevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190 · cited 1×
“The prevalence of overweight and obesity is increasing worldwide.(1) A comparison of data from 1976–80(2) with that from 1999–2000 shows that the prevalence of overweight (defined as body mass index, BMI, of 25–29.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · cited 2×
“The risk of developing heart failure was two-fold higher in obese individuals, compared with subjects with a normal body-mass index.(45) On multivariate analysis adjusting for risk factors including hypertension, coronary artery disease and left ventricular hypertrophy, there was an excess risk of 5% in men and 7% in…”
Background
Cited by
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
“Obesity is a risk factor for a variety of chronicconditionsincludingdiabetes,hypertension,highcholesterol,stroke,heart disease, certain cancers, and arthritis.(26) Higher grades of obesity are associated withexcessmortality,primarilyfromcardiovasculardisease,diabetes,andcertain cancers.”
BackgroundArmstrong, M. J., Mottershead, T. A., Ronksley, P. E., Sigal, R. J., Campbell, T. S., & Hemmelgarn, B. R. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00892.x · Cited by 586
“The health consequences of excess weight include an increased risk of type 2 diabetes, cardiovascular disease, high blood pressure, osteoarthritis, some cancers and a decrease in quality of life (2).”
BackgroundMeasuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin
Shah, N. R., & Braverman, E. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033308 · Cited by 554
“Obesity is associated with increased risk of diabetes, hypertension, heart disease, stroke, cancer, dyslipidemia, liver and gallbladder disease, sleep apnea and respiratory problems, osteoarthritis, abnormal menses and infertility [3].”
BackgroundReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Dietary phytochemicals and their potential effects on obesity: A review
González-Castejón, M., & Rodriguez-Casado, A. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.07.004 · Cited by 372
“[91].”
Metadata
- Authors
- Malnick, S. D. H.
- Affiliations
- Kaplan Medical Center (IL)
- Corresponding author
- Malnick, S.D.H.
- ORCID
- Malnick, S.D.H.
- Venue
- QJM
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08-12
- Volume
- 99
- Issue
- 9
- Pages
- 565-579
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2725
- 1460-2393
- OpenAlex
- W2133741030
- Cited by
- 579
- References
- 185
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 20 · 2023: 23 · 2022: 26 · 2021: 33 · 2020: 28 · 2019: 30 · 2018: 38 · 2017: 30 · 2016: 40 · 2015: 50 · 2014: 53 · 2013: 67 · 2012: 43
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- QJM (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Keywords
- obesity, overweight, body mass index, obesity-related mortality, U-shaped relationship, obesity prevalence, diabetes mellitus, hypertension, dyslipidemia, ischemic heart disease, cancer mortality, smoking, obesity treatment, bariatric surgery, obesity pharmacotherapy
- MeSH terms
- Adolescent, Adult, Aged, Cardiovascular Diseases, Digestive System Diseases, Female, Genital Diseases, Male, Humans, Male, Metabolic Diseases, Middle Aged, Neoplasms, Obesity, Osteoarthritis, Postoperative Complications, Pregnancy, Respiratory Tract Diseases, Risk Factors, Female Urogenital Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The medical complications of obesity. https://app.cochat.ai/papers/10.1093/qjmed/hcl085
- The paper
- Malnick, S. D. H. (2006). The medical complications of obesity. QJM. https://doi.org/10.1093/qjmed/hcl085
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.